In this analysis of patients with myeloperoxidase-ANCA-positive AAV, all urinary complement C3 fragment levels were elevated significantly compared with healthy controls (P <.01 for all).
Novartis posts positive phase III ALIGN data for Vanrafia in IgAN, showing slower kidney decline as it eyes full approval in 2026.
Under the agreement, SanegeneBio has granted Genentech exclusive worldwide rights to develop and commercialize the undisclosed program.
Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 9:30 AM ESTCompany ParticipantsJohn Butler ...
In a study, blocking the immune system complement protein C3 was shown to reduce MS disease severity in older mice but not in ...
Michael Sagner, MD, is a clinical advisor in Longevity and Preventive Medicine at Ageing Research at King’s (ARK), Director of the European Society of Preventive Medicine, founder of The Serena Clinic ...
Jan 27 (Reuters) - Enterprise artificial intelligence software provider C3.AI (AI.N), opens new tab is in talks to merge with software company Automation Anywhere, The Information reported on Tuesday, ...
The study of immune inflammatory responses centers on the intricate molecular pathways that both initiate and modulate these processes. Inflammation is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results